| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MedAvail Holdings, Inc. | Director, 10%+ Owner | Common Stock | 11,458,679 | $65,281,240 | $5.70 | 04 Apr 2022 | Direct |
| Augmedix, Inc. | Director, 10%+ Owner | Common Stock | 8,696,146 | $42,176,308 | $4.85 | 02 May 2023 | Direct |
| FATE THERAPEUTICS INC | Director, 10%+ Owner | Common Stock | 8,977,624 | $12,568,673 | $1.40 | 02 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | 02 Jul 2025 | 0 | $0 | 3 | Director, 10%+ Owner | 03 Jul 2025, 16:03 |
| /report/000110465923056206-redco-ii-master-fund-l-p-2023-05-02 | Augmedix, Inc. | 02 May 2023 | 0 | $0 | 3 | Director, 10%+ Owner | 04 May 2023, 21:30 |
| /report/000110465922043370-redco-ii-master-fund-l-p-2022-04-04 | MedAvail Holdings, Inc. | 04 Apr 2022 | 0 | $0 | 3 | Director, 10%+ Owner | 06 Apr 2022, 21:46 |